Listen Download Podcast
  • RFI English News flash 04h00 - 04h10 GMT Mon-Fri
    News bulletin 12/08 04h00 GMT
  • Paris Live AM 04h10 - 04h30 GMT Mon-Fri
    Features and analysis 12/08 04h10 GMT
  • RFI English News flash 05h00 - 05h10 GMT Mon-Fri
    News bulletin 12/08 05h00 GMT
  • Paris Live AM 05h10 - 05h30 GMT Mon-Fri
    Features and analysis 12/08 05h10 GMT
  • RFI English News flash 06h00 - 06h10 GMT Mon-Fri
    News bulletin 12/08 06h00 GMT
  • Paris Live AM 06h10 - 06h30 GMT Mon-Fri
    Features and analysis 12/08 06h10 GMT
  • RFI English News flash 06h30 - 06h33 GMT Mon-Fri
    News bulletin 12/08 06h30 GMT
  • Paris Live AM 06h33 - 06h59 GMT Mon-Fri
    Features and analysis 12/08 06h33 GMT
  • RFI English News flash 07h00 - 07h10 GMT Mon-Fri
    News bulletin 12/08 07h00 GMT
  • RFI English News flash 07h30 - 07h33 GMT Mon-Fri
    News bulletin 12/08 07h30 GMT
  • RFI English News flash 14h00 - 14h03 GMT Sat-Sun
    News bulletin 12/04 14h00 GMT
  • RFI English News flash 14h00 - 14h06 GMT Mon-Fri
    News bulletin 12/07 14h00 GMT
  • Paris Live Weekend 14h03 - 14h30 GMT Sat-Sun
    Features and analysis 12/04 14h03 GMT
  • Paris Live PM 14h06 - 14h30 GMT Mon-Fri
    Features and analysis 12/07 14h06 GMT
  • RFI English News flash 14h30 - 14h33 GMT Mon-Fri
    News bulletin 12/07 14h30 GMT
  • Paris Live PM 14h33 - 14h59 GMT Mon-Fri
    Features and analysis 12/07 14h33 GMT
  • RFI English News flash 16h00 - 16h03 GMT Sat-Sun
    News bulletin 12/04 16h00 GMT
  • RFI English News flash 16h00 - 16h06 GMT Sat-Sun
    News bulletin 12/07 16h00 GMT
  • Paris Live Weekend 16h03 - 16h30 GMT Sat-Sun
    Features and analysis 12/04 16h03 GMT
  • RFI English News flash 16h30 - 16h33 GMT Mon-Fri
    News bulletin 12/07 16h30 GMT
  • Paris Live Weekend 16h33 - 17h00 GMT Sat-Sun
    Features and analysis 12/04 16h33 GMT
To take full advantage of multimedia content, you must have the Flash plugin installed in your browser. To connect, you need to enable cookies in your browser settings. For an optimal navigation, the RFI site is compatible with the following browsers: Internet Explorer 8 and above, Firefox 10 and +, Safari 3+, Chrome 17 and + etc.
Europe

French drug trial patient dies after being left brain-dead for week

media French Health Minister Marisol Touraine and clinical neurology professor Gilles Hedan at a press conference about the drug trial tragedy Reuters/Stephane Mahe

The man who was left brain-dead after a drugs trial in a French laboratory has died. Five other volunteers remain in hospital in a "stable condition", the hopsital that has been treating them said.

The Rennes university hospital announced the man's death on Sunday.

He had been admitted a week earlier suffering from side-effects incurred during a trial for a pain and mood disorder medication developed by a Portuguese company, Bial, and tested at the Biotrial private laboratory in the western French city.

The five other men who had taken the highest dose of the drug remained in hospital on Sunday.

Three of them were suffering a "handicap that could be irreversible" and another had neurological problems, the neurology department head, Pierre-Gilles Edan, said on Friday.

The other had shown no symptoms but was being monitored.

The 84 other volunteers exposed to the drug have all been contacted and 10 came to the hospital for check-ups but did not show the same "anomalies" as the hospitalised patients, a statement said.

Bial is cooperating with the investigation and vows it followed "international best practice" in developing the drug.

Related
 
Sorry but the period of time connection to the operation is exceeded.